2006European Journal of AnaesthesiologyRequires access

Cardiovascular safety of the cyclooxygenase-2 selective inhibitor parecoxib sodium: Review of pooled data from surgical studies

Stephan A. Schug, F. Camu, Girish P. Joshi, Sharon Pan, Raymond Cheung

Open publisher page 9 citations

Abstract

1University of Western Australia, Perth, Australia; 2Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 3University of Texas Southwestern Medical Center at Dallas

About this research paper

What this paper is about

1University of Western Australia, Perth, Australia; 2Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 3University of Texas Southwestern Medical Center at Dallas

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

1University of Western Australia, Perth, Australia; 2Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 3University of Texas Southwestern Medical Center at Dallas

Key concepts: Medicine, Parecoxib, Cyclooxygenase, Pharmacology, Anesthesia, Enzyme, Biochemistry, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Cardiovascular safety of the cyclooxygenase-2 selective inhibitor parecoxib sodium: Review of pooled data from surgical studies — Research Paper | ScholarLens